Financial Year |
March 31 2023 |
Monetary Funds |
19,226,723,000.62 |
Held-for-trading Financial Assets |
690,392,876.71 |
Notes Receivable |
246,564,512.94 |
Accounts Receivable |
13,815,217,944.52 |
Advances to Suppliers |
1,409,141,284.80 |
Other Receivables |
546,878,909.60 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
19,695,356,425.59 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
427,692,894.19 |
Other Current Assets |
3,673,579,285.14 |
Total Current Assets |
62,464,868,830.38 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
4,807,022,936.80 |
Long-term Equity Investment |
3,979,809,807.15 |
Investment Properties |
661,468,109.44 |
Fixed Assetes |
7,572,212,152.98 |
Under-construction Projects |
307,670,909.29 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
4,353,833,408.88 |
R&D expenses |
380,629,260.45 |
Goodwill |
151,439,442.39 |
Long-Term Deferred and Prepaid Expenses |
51,155,468.85 |
Deferred Income Tax Assets |
377,237,433.11 |
Other Non-Current Assets |
94,492,399.42 |
Sub-Total of Non-Current Assets |
24,278,529,569.72 |
Total Assets |
86,743,398,400.10 |
Short-Term Loans |
13,529,175,438.03 |
Trading Financial liabilities |
-- |
Notes Payable |
17,908,870,042.02 |
Accounts Payable |
17,184,838,240.16 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
899,496,359.65 |
Taxes Payable |
475,264,663.98 |
Interest Payable |
-- |
Dividend Payable |
153,663,379.11 |
Other payables |
3,597,161,973.03 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
2,325,662,000.64 |
Other Current Liabilities |
275,283,576.64 |
Sub-Total of Current Liabilities |
59,192,421,471.37 |
Long-term Loans |
2,657,687,006.95 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
56,197,197.29 |
Special Payable |
-- |
Estimatied Liabilities |
560,837,213.24 |
Deferred Income Tax Liabilities |
126,224,206.71 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
4,500,360,226.88 |
Total Liabilities |
63,692,781,698.25 |
Paid-In Capital(Or Share Stock) |
4,616,244,222.00 |
Capital Surplus |
3,655,473,981.46 |
Surplus Reserve |
202,335,263.00 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
5,207,813,256.70 |
Minority Stockholder's Interest |
9,327,529,071.66 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,723,087,630.19 |
Owner's Equity(Stockholder's Equity) |
23,050,616,701.85 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
86,743,398,400.10 |